Among the 3,067 enrolled participants, 307 participants with diabetes, 4 with missing fasting glucose, fasting insulin or triglyceride, and 37 without CTA or MRI examinations were excluded, and a total of 2,719 participants were available for final analysis (Fig. 1). The gene discussed is INS; the disease is diabetes mellitus.